Hagbi Z, Gielman S, Dorfman A, Eilam D
Anim Cogn. 2022; 26(2):655-666.
PMID: 36318351
DOI: 10.1007/s10071-022-01710-9.
Dorfman A, Eilam D
Anim Cogn. 2020; 24(3):407-418.
PMID: 33048261
DOI: 10.1007/s10071-020-01441-9.
Guo H, Huang B, Wang Y, Zhang Y, Ma Q, Lv P
Cell Mol Neurobiol. 2020; 40(6):991-997.
PMID: 31927718
PMC: 11448922.
DOI: 10.1007/s10571-020-00788-4.
Fischer K, Houston A, Desai R, Doyle M, Bergman J, Mian M
Psychopharmacology (Berl). 2018; 235(5):1371-1387.
PMID: 29468294
PMC: 5999338.
DOI: 10.1007/s00213-018-4848-1.
Gomez-Marin A, Oron E, Gakamsky A, Dan Valente , Benjamini Y, Golani I
Sci Rep. 2016; 6:27555.
PMID: 27271799
PMC: 4897781.
DOI: 10.1038/srep27555.
Obsessive-compulsive disorder: Insights from animal models.
Szechtman H, Ahmari S, Beninger R, Eilam D, Harvey B, Edemann-Callesen H
Neurosci Biobehav Rev. 2016; 76(Pt B):254-279.
PMID: 27168347
PMC: 5833926.
DOI: 10.1016/j.neubiorev.2016.04.019.
Nucleus accumbens core and pathogenesis of compulsive checking.
Gonzalez J, Dvorkin-Gheva A, Silva C, Foster J, Szechtman H
Behav Pharmacol. 2014; 26(1-2):200-16.
PMID: 25426580
PMC: 5398318.
DOI: 10.1097/FBP.0000000000000112.
Performance of compulsive behavior in rats is not a unitary phenomenon - validation of separate functional components in compulsive checking behavior.
Tucci M, Dvorkin-Gheva A, Johnson E, Cheon P, Taji L, Agarwal A
Eur J Neurosci. 2014; 40(6):2971-9.
PMID: 24935528
PMC: 4215607.
DOI: 10.1111/ejn.12652.
Repeated exposure to MDMA and amphetamine: sensitization, cross-sensitization, and response to dopamine D₁- and D₂-like agonists.
Bradbury S, Gittings D, Schenk S
Psychopharmacology (Berl). 2012; 223(4):389-99.
PMID: 22562523
DOI: 10.1007/s00213-012-2726-9.
Freedom of movement and the stability of its unfolding in free exploration of mice.
Fonio E, Benjamini Y, Golani I
Proc Natl Acad Sci U S A. 2009; 106(50):21335-40.
PMID: 19934049
PMC: 2795555.
DOI: 10.1073/pnas.0812513106.
Dopamine D2/D3 receptor agonist quinpirole impairs spatial reversal learning in rats: investigation of D3 receptor involvement in persistent behavior.
Boulougouris V, Castane A, Robbins T
Psychopharmacology (Berl). 2008; 202(4):611-20.
PMID: 18836703
DOI: 10.1007/s00213-008-1341-2.
Dopaminergic and serotonergic modulation of persistent behaviour in the reinforced spatial alternation model of obsessive-compulsive disorder.
Kontis D, Boulougouris V, Papakosta V, Kalogerakou S, Papadopoulos S, Poulopoulou C
Psychopharmacology (Berl). 2008; 200(4):597-610.
PMID: 18622751
DOI: 10.1007/s00213-008-1241-5.
Modulation of quinpirole-induced compulsive-like behavior in rats by environmental changes: implications for OCD rituals and for exploration and navigation.
Zadicario P, Ronen S, Eilam D
BMC Neurosci. 2007; 8:23.
PMID: 17386094
PMC: 1847440.
DOI: 10.1186/1471-2202-8-23.
Age differences in the sensitivity to clomipramine in an animal model of obsessive-compulsive disorder.
Fernandez-Guasti A, Ulloa R, Nicolini H
Psychopharmacology (Berl). 2003; 166(3):195-201.
PMID: 12589517
DOI: 10.1007/s00213-002-1301-1.
Compulsive checking behavior of quinpirole-sensitized rats as an animal model of Obsessive-Compulsive Disorder(OCD): form and control.
Szechtman H, Eckert M, Tse W, Boersma J, Bonura C, McClelland J
BMC Neurosci. 2001; 2:4.
PMID: 11316464
PMC: 31431.
DOI: 10.1186/1471-2202-2-4.
Behavioural disturbances associated with hyperdopaminergia in dopamine-transporter knockout mice.
Spielewoy C, Roubert C, Hamon M, Nosten-Bertrand M, Betancur C, Giros B
Behav Pharmacol. 2000; 11(3-4):279-90.
PMID: 11103882
PMC: 2668803.
DOI: 10.1097/00008877-200006000-00011.
A risk-benefit assessment of drugs used in the management of obsessive-compulsive disorder.
Carpenter L, McDougle C, Epperson C, Price L
Drug Saf. 1996; 15(2):116-34.
PMID: 8884163
DOI: 10.2165/00002018-199615020-00004.
Dynamics of behavioral sensitization induced by the dopamine agonist quinpirole and a proposed central energy control mechanism.
Szechtman H, Talangbayan H, Canaran G, Dai H, Eilam D
Psychopharmacology (Berl). 1994; 115(1-2):95-104.
PMID: 7862919
DOI: 10.1007/BF02244757.
Time course of amphetamine-induced locomotor stereotypy in an open field.
Mueller K, Kunko P, Whiteside D, Haskett C
Psychopharmacology (Berl). 1989; 99(4):501-7.
PMID: 2594917
DOI: 10.1007/BF00589899.
A temporal and spatial scaling hypothesis for the behavioral effects of psychostimulants.
Paulus M, Geyer M
Psychopharmacology (Berl). 1991; 104(1):6-16.
PMID: 1679242
DOI: 10.1007/BF02244547.